Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.
about
Gastrointestinal and Hepatic Complications of Immune Checkpoint Inhibitors.A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanoma.[Adverse effects of immunotherapy : Clinical aspects, radiological and nuclear medicine results].Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy.Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.A Severe Case of Ipilimumab-Induced Ileocolitis Refractory to Glucocorticosteroids and Infliximab.
P2860
Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@ast
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@en
type
label
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@ast
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@en
prefLabel
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@ast
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@en
P2093
P2860
P50
P1433
P1476
Ipilimumab and immune-mediated ...... of anti-CTLA4 induced ileitis.
@en
P2093
Chiara Taffon
Delia De Lisi
Elisa Pagliara
Olga Venditti
Sofia Battisi
P2860
P2888
P356
10.1186/S12885-015-1074-7
P407
P50
P577
2015-03-01T00:00:00Z
P5875
P6179
1002529535